摘要:
The present invention provides a radioactive labeling method for neuropeptide Y (NPY) compound and a mammalian diagnostic radioactive targeting medicine with NPY peptide being modified at position 27th to 36th, and after binding with the chelating agent and labeling the radiation nucleus 66Ga, 67Ga, 68Ga, 177Lu or 111In to provide a radioactive targeting medicine for multi-type breast cancer diagnosis and treatment.
摘要:
The present invention provides a radioactive labeling method for neuropeptide Y (NPY) compound and a mammalian diagnostic radioactive targeting medicine with NPY peptide being modified at position 27th to 36th, and after binding with the chelating agent and labeling the radiation nucleus 66Ga67Ga68Ga177Lu or 111In to provide a radioactive targeting medicine for multi-type breast cancer diagnosis and treatment.
摘要:
The invention features a novel precursor provided for radioisotope labeling with ligands for specific binding of prostate-specific membrane antigen (PSMA) for prostate cancer diagnosis and treatment, and the pharmacophore of a PSMA inhibitor composed of three molecules of glutamic acid, urea and lysine is provided with three variable linkers based on pharmacological activity of the PSMA inhibitor for labeling with radioactive nucleus Ga-67, Ga-68, In-111, Lu-177, Cu-64, or Y-90 through a chelating agent for imaging analysis of human tumor models of prostate cancer and serving as a PSMA-targeted radioligand therapy for prostate cancer diseases.
摘要:
The invention features a novel precursor provided for radioisotope labeling with ligands for specific binding of prostate-specific membrane antigen (PSMA) for prostate cancer diagnosis and treatment, and the pharmacophore of a PSMA inhibitor composed of three molecules of glutamic acid, urea and lysine is provided with three variable linkers based on pharmacological activity of the PSMA inhibitor for labeling with radioactive nucleus Ga-67, Ga-68, In-111, Lu-177, Cu-64, or Y-90 through a chelating agent for imaging analysis of human tumor models of prostate cancer and serving as a PSMA-targeted radioligand therapy for prostate cancer diseases.
摘要:
A process of evaluating blood-brain barrier permeability of a stroke rat by using fluorescent substance is disclosed. This process uses an Evans blue dye having spontaneous fluorescence properties, in combination with the use of a new non-invasive in vivo imaging system (IVIS), to obtain fluorescent signals so as to assess the change in the blood-brain barrier permeability of rodents after a cerebral artery stroke model surgery. In operation, an Evans blue dye is injected into a stroke rat of middle cerebral artery occlusion model. A non-invasive in vivo imaging system is used to detect the fluorescence distribution of the whole brain, and obtain images combined by the fluorescence images and optical images for the whole brain tissue. Thereby, the change in the blood-brain barrier permeability of the stroke rat can be completely realized.
摘要:
A process of evaluating blood-brain barrier permeability of a stroke rat by using fluorescent substance is disclosed. This process uses an Evans blue dye having spontaneous fluorescence properties, in combination with the use of a new non-invasive in vivo imaging system (IVIS), to obtain fluorescent signals so as to assess the change in the blood-brain barrier permeability of rodents after a cerebral artery stroke model surgery. In operation, an Evans blue dye is injected into a stroke rat of middle cerebral artery occlusion model. A non-invasive in vivo imaging system is used to detect the fluorescence distribution of the whole brain, and obtain images combined by the fluorescence images and optical images for the whole brain tissue. Thereby, the change in the blood-brain barrier permeability of the stroke rat can be completely realized.
摘要:
A method is provided to label dopamine D2 receptors at striatum and areas outside of striatum. A radiosynthesized ligand of iodine(I)-123-Epidepride is used. The I-123-Epidepride can be strongly bonded to the D2 receptor and has a rare characteristic of non-specificity. Hence, it is suitable for developing a tracer for areas outside of striatum, where D2 receptor densities are low. Besides, I-123-Epidepride can be passed through blood brain barrier and has a high affinity to an animal's brain, so it can be used to develop medicines for diagnosing schizophrenia.
摘要:
A capacitive pressure transducer includes a conductive diaphragm positioned between pneumatically separated chambers defined by concave body members. The diaphragm is fixed and sealingly coupled at its periphery to the peripheral rim of the concave body members. The diaphragm can be supported in tension by the peripheral rim of the body members. An electrode assembly, supported by one body member, establishes a substantially planar conductive surface opposite to and spaced apart by a nominal gap from the conductive diaphragm. The capacitive pressure transducer further includes a thermal compensation element securely coupled to the inside surface or the outside surface of one of the concave body members and/or to the electrode. The thermal compensation element has a different coefficient of thermal expansion from that of the concave body member or electrode to which it is attached. The combination of the concave body member or electrode and thermal compensation element having different coefficients of thermal expansion results in a bimetallic action which produces a thermally dependent force that compensates or counter-acts the thermally induced changes in the characteristics of the transducer.
摘要:
A capacitive pressure transducer includes a conductive diaphragm positioned between pneumatically separated chambers. The diaphragm is fixed and sealingly coupled at its periphery to the peripheral rim of a concave body member. The diaphragm is supported in tension by the peripheral rim of the body member. An electrode assembly, supported by the body member establishes a substantially planar conductive surface opposite to and spaced apart by a nominal gap from the conductive diaphragm. The body member includes a yieldable portion that is adapted to radially expand its peripheral rim in response to forces applied to the body member. When the forces are applied, the body member becomes strained beyond its elastic limit and takes a permanent set whereby the peripheral rim is expanded and the diaphragm becomes tensioned. The tension in the diaphragm can be determined as a function of the geometry of the body member and deformation resulting from the forces applied. Additional forces can be applied at a later point in time in order to change or adjust the tension in the diaphragm.
摘要:
A compact force transducer has at least one flexible beam mounted at one or both its ends to a force summing member or members. The force-to-be-measured is applied to the force summing member along a first axis generally transverse to the beams to deform the beam elastically, without overstressing, through a displacement d. A sensor member carries a conductive surface and is coupled to the beam member. In a parallelogram form, there are a parallel pair of beam members extending between two force summing members and a sensor member is secured to each beam member at or near its point of inflection. One sensor member includes multiple arms that sandwich the other sensor member to produce a linear, push-pull mode of operation. In a low cost cantilevered beam form, the sensor is coupled to the beam at the force summing member in a parallel, spaced relationship. In a hybrid push-pull form, the transducer uses a two beam parallelogram construction with cantilevered sensors (1) coupled rigidly to each beam adjacent one force summing member with a hinge coupling between the beam and this one force summing member, and (2) extending generally in a parallel spaced relationship with respect to an associated one of the beams.